The use of triple therapy, ICS/LABA/LAMA, in the treatment of asthma: A real-life Latin-American specialized centers experience
Journal of Allergy and Clinical Immunology: Global · 2026-01 · 5 (1) · 100606
DOI: 10.1016/j.jacig.2025.100606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2026-01. Verfasst von Ricardo Martinez-Tenopala und 9 weiteren Autor:innen. Beteiligte Einrichtung: AlergiaMx, Benito Juarez, Mexico City, Mexico. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The use of triple therapy with inhaled corticosteroids (ICSs), long-acting beta-agonists (LABAs), and long-acting muscarinic antagonists (LAMAs) is increasingly common in asthma management, particularly in patients with uncontrolled disease. However, real-world data from Latin-American settings are limited.
Objective
We sought to compare asthma control and exacerbation frequency among patients receiving ICS/LABA/LAMA versus ICS/LABA alone at steps 4 and 5 of the Global Initiative for Asthma guidelines in specialized centers in Mexico.
Methods
A cross-sectional observational study was conducted in 3 allergy and pulmonary clinics. Adult patients with asthma receiving maintenance therapy at Global Initiative for Asthma step 4 or 5 were recruited. Demographic, clinical, and spirometric data were collected. Asthma control was assessed using the asthma control test. Comparisons were made between patients receiving ICS/LABA/LAMA and those receiving ICS/LABA only. Ordinal logistic regression was used to identify predictors of asthma control.
Results
Among 279 patients (71% female; mean age, 51.4 ± 12.3 years), 79 received triple therapy. At step 4, ICS/LABA/LAMA users had better asthma control than those on ICS/LABA alone (P = .03). At step 5, ICS/LABA/LAMA users showed lower asthma control test scores and more frequent exacerbations (P < .05), likely reflecting greater baseline severity. At step 4, ICS/LABA/LAMA use was associated with better asthma control in the unadjusted analysis; however, this association was no longer statistically significant after adjustment in the ordinal logistic regression model.
Conclusions
ICS/LABA/LAMA may improve asthma control at step 4 but not at step 5, possibly due to more severe disease and previous use of biologics in the latter group. These findings highlight the need for tailored therapy and better phenotyping in severe asthma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AlergiaMx, Benito Juarez, Mexico City, Mexico.
- Facultad Mexicana de Medicina, Universidad La Salle Mexico, Tlalpan, Mexico City, Mexico.
- Subdireccion de Enseñanza Y Calidad de La Secretaria de Salud de Baja California Sur, La Paz, Mexico.
- Sin Alergia GDL, Guadalajara, Jalisco, Mexico.
- Pathology & Immunohistochemistry Department, Hospital General de Mexico Dr. Eduardo Liceaga, Cuauhtemoc, Mexico City, Mexico.
Zitieren
APA
Martinez-Tenopala, R., Gonzalez-Uribe, V., Gomez-Nuñez, C. A., Prieto-Gomez, J., Rendon-Salazar, M. J., Hernandez-Hernandez, T., Pozo Beltran, C. F., Alcocer-Arreguin, C. R., de Baro Alvarez, P., & Mojica-Gonzalez, Z. S. (2026). The use of triple therapy, ICS/LABA/LAMA, in the treatment of asthma: A real-life Latin-American specialized centers experience. Journal of Allergy and Clinical Immunology: Global, 5(1), 100606. https://doi.org/10.1016/j.jacig.2025.100606
Vancouver
Martinez-Tenopala R, Gonzalez-Uribe V, Gomez-Nuñez CA, Prieto-Gomez J, Rendon-Salazar MJ, Hernandez-Hernandez T, et al. The use of triple therapy, ICS/LABA/LAMA, in the treatment of asthma: A real-life Latin-American specialized centers experience. Journal of Allergy and Clinical Immunology: Global. 2026;5(1):100606. doi:10.1016/j.jacig.2025.100606
BibTeX
@article{MartinezTenopala2026,
author = {Martinez-Tenopala, Ricardo and Gonzalez-Uribe, Victor and Gomez-Nuñez, Carlos Andres and Prieto-Gomez, Jimena and Rendon-Salazar, Maria Julia and Hernandez-Hernandez, Tamara and Pozo Beltran, Cesar F and Alcocer-Arreguin, Christian R and de Baro Alvarez, Paola and Mojica-Gonzalez, Zaira S},
title = {The use of triple therapy, ICS/LABA/LAMA, in the treatment of asthma: A real-life Latin-American specialized centers experience},
journal = {Journal of Allergy and Clinical Immunology: Global},
year = {2026},
volume = {5},
number = {1},
pages = {100606},
doi = {10.1016/j.jacig.2025.100606}
}
EUVIMED